|
| | Publication Year | Title | Author(s) |
| 1 | 19-Dec-2023 | Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer. | Tan, Tao; Mouradov, Dmitri; Lee, Margaret; Gard, Grace; Hirokawa, Yumiko; Li, Shan; Lin, Cong; Li, Fuqiang; Luo, Huijuan; Wu, Kui; Palmieri, Michelle; Leong, Evelyn; Clarke, Jordan; Sakthianandeswaren, Anuratha; Brasier, Helen; Tie, Jeanne; Tebbutt, Niall C ; Jalali, Azim; Wong, Rachel; Burgess, Antony W; Gibbs, Peter; Sieber, Oliver M |
| 2 | 14-Mar-2023 | A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. | Tan, Lavinia; Tran, Ben; Tie, Jeanne; Markman, Ben; Ananda, Sumi; Tebbutt, Niall C ; Michael, Michael; Link, Emma; Wong, Stephen Q; Chandrashekar, Sushma; Guinto, Jerick; Ritchie, David; Koldej, Rachel; Solomon, Benjamin J; McArthur, Grant A; Hicks, Rodney J; Gibbs, Peter; Dawson, Sarah-Jane; Desai, Jayesh |
| 3 | 3-Jan-2023 | Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death. | Jenkins, Laura J; Luk, Ian Y; Fairlie, Walter Douglas ; Lee, Erinna F; Palmieri, Michelle; Schoffer, Kael L; Tan, Tao; Ng, Irvin; Vukelic, Natalia; Tran, Sharon; Tse, Janson W T; Nightingale, Rebecca; Alam, Zakia; Chionh, Fiona; Iatropoulos, George F ; Ernst, Matthias ; Afshar-Sterle, Shoukat ; Desai, Jayesh; Gibbs, Peter; Sieber, Oliver M; Dhillon, Amardeep S ; Tebbutt, Niall C ; Mariadason, John M |
| 4 | 2023 | Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population. | Walpole, Imogen; Lee, Belinda; Shapiro, Jeremy; Thomson, Benjamin; Lipton, Lara; Ananda, Sumitra; Usatoff, Val; Mclachlan, Sue-Ann; Knowles, Brett; Fox, Adrian; Wong, Rachel; Cooray, Prasad; Burge, Matthew; Clarke, Kate; Pattison, Sharon; Nikfarjam, Mehrdad ; Tebbutt, Niall C ; Harris, Marion; Nagrial, Adnan; Zielinski, Rob; Chee, Cheng Ean; Gibbs, Peter |
| 5 | 3-May-2021 | Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study. | Tie, Jeanne; Wang, Yuxuan; Cohen, Joshua; Li, Lu; Hong, Wei; Christie, Michael; Wong, Hui Li; Kosmider, Suzanne; Wong, Rachel; Thomson, Benjamin; Choi, Julian; Fox, Adrian; Field, Kathryn; Burge, Matthew; Shannon, Jenny; Kotasek, Dusan; Tebbutt, Niall C ; Karapetis, Christos; Underhill, Craig; Haydon, Andrew; Schaeffer, Joy; Ptak, Janine; Tomasetti, Cristian; Papadopoulos, Nicholas; Kinzler, Kenneth W; Vogelstein, Bert; Gibbs, Peter |
| 6 | 15-Feb-2021 | Prognostic Significance of Post-Surgery Circulating Tumor DNA in Non-Metastatic Colorectal Cancer: Individual Patient Pooled Analysis of Three Cohort Studies. | Tie, Jeanne; Cohen, Joshua D; Lo, Serigne N; Wang, Yuxuan; Li, Lu; Christie, Michael; Lee, Margaret; Wong, Rachel; Kosmider, Suzanne; Skinner, Iain; Wong, Hui Li; Lee, Belinda; Burge, Matthew E; Yip, Desmond; Karapetis, Christos S; Price, Timothy J; Tebbutt, Niall C ; Haydon, Andrew M; Ptak, Janine; Schaeffer, Mary J; Silliman, Natalie; Dobbyn, Lisa; Popoli, Maria; Tomasetti, Cristian; Papadopoulos, Nickolas; Kinzler, Kenneth W; Vogelstein, Bert; Gibbs, Peter |
| 7 | 2021 | Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials Group. | Dunn, Catherine; Hong, Wei; Gibbs, Peter; Ackland, Stephen; Sjoquist, Katrin; Tebbutt, Niall C ; Price, Timothy; Burge, Matthew |
| 8 | Mar-2020 | Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. | Williams, David S ; Mouradov, Dmitri; Browne, Clare; Palmieri, Michelle; Elliott, Meg J; Nightingale, Rebecca; Fang, Catherine G; Li, Rita; Mariadason, John M ; Faragher, Ian; Jones, Ian T; Churilov, Leonid ; Tebbutt, Niall C ; Gibbs, Peter; Sieber, Oliver M |
| 9 | 2020 | The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]. | Clarke, Stephen John; Burge, Matthew; Feeney, Kynan; Gibbs, Peter; Jones, Kristian; Marx, Gavin; Molloy, Mark P; Price, Timothy; Reece, William H H; Segelov, Eva; Tebbutt, Niall C |
| 10 | Oct-2018 | Targeted therapy for metastatic colorectal cancer. | Price, Timothy J; Tang, Monica; Gibbs, Peter; Haller, Daniel G; Peeters, Marc; Arnold, Dirk; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew; Shapiro, Jeremy |
| 11 | Apr-2018 | Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. | Tang, Monica; Price, Timothy Jay; Shapiro, Jeremy; Gibbs, Peter; Haller, Daniel G; Arnold, Dirk; Peeters, Marc; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew |
| 12 | May-2016 | Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015. | Price, Timothy J; Thavaneswaran, Subotheni; Burge, Matthew; Segelov, Eva; Haller, Daniel G; Punt, Cornelis Ja; Arnold, Dirk; Karapetis, Christos S; Tebbutt, Niall C ; Pavlakis, Nick; Gibbs, Peter; Shapiro, Jeremy D |
Loading...
2
0
20
0
false